Market intelligence across pharma, MedTech, and digital health.
3,460+ published studies covering therapeutics, diagnostics, devices, and healthcare services — sized bottom-up and top-down, validated by our dedicated Healthcare & Medical Devices research team, and delivered with country-level detail.
The Healthcare & Medical Devices Research Team
This vertical is covered by a dedicated research group inside Fundamental Business Insights that tracks the global healthcare and medical technology industry full-time. Our analysts follow clinical adoption trends, regulatory developments, reimbursement policy, healthcare infrastructure investment, and evolving patient-care requirements as they happen — not just at the point a report is commissioned.
Every estimate in this vertical is built from primary conversations with healthcare stakeholders and cross-checked against company financial disclosures, regulatory publications, clinical literature, and government health databases, then reconciled through both bottom-up and top-down modeling before an internal quality review.
Who we interview
Clinical KOLs, regulatory affairs heads, hospital procurement leads, and MedTech product & commercial teams.
Regulatory fluency
Analysts track FDA, EMA, and regional approval pathways so device and drug forecasts reflect real timelines.
Reimbursement modeling
Forecasts factor in payer policy and reimbursement shifts, not just clinical or technology adoption curves.
Sub-domains we track
Healthcare & Medical Devices reports on this site span the following sub-domains. Reports aren't filed under these as separate sub-categories yet — search or browse the full list below to find a specific market.
Pharmaceuticals
Small-molecule and branded/generic drug markets across therapeutic areas and dosage forms.
Biotechnology & Advanced Therapies
Cell and gene therapies, biologics, and next-generation biotech platforms.
Medical Devices
Diagnostic, surgical, monitoring, and implantable device categories across care settings.
Medical Diagnostics
In-vitro diagnostics, imaging, and point-of-care testing markets.
Analytical & Laboratory Technologies
Lab instrumentation, reagents, and analytical platforms used in research and clinical settings.
Healthcare IT & Digital Health
EHR platforms, telehealth, remote monitoring, and clinical software markets.
Clinical & Healthcare Services
Hospital operations, outpatient care, and healthcare service delivery models.
Veterinary Healthcare
Animal health diagnostics, pharmaceuticals, and veterinary device markets.
Life Science Research Tools
Instruments, reagents, and platforms supporting pharmaceutical and academic research.
Secondary sources behind this vertical
Alongside primary interviews, every Healthcare & Medical Devices estimate is checked against these authoritative public and regulatory sources.
| Secondary source | Official website |
|---|---|
| World Health Organization (WHO) | who.int ↗ |
| U.S. Food & Drug Administration (FDA) | fda.gov ↗ |
| European Medicines Agency (EMA) | ema.europa.eu ↗ |
| Centers for Disease Control and Prevention (CDC) | cdc.gov ↗ |
| National Institutes of Health (NIH) | nih.gov ↗ |
| National Center for Biotechnology Information (NCBI) | ncbi.nlm.nih.gov ↗ |
| PubMed | pubmed.ncbi.nlm.nih.gov ↗ |
| ClinicalTrials.gov | clinicaltrials.gov ↗ |
| International Organization for Standardization (ISO) | iso.org ↗ |
| ASTM International | astm.org ↗ |
| Advanced Medical Technology Association (AdvaMed) | advamed.org ↗ |
| Medical Device Innovation Consortium (MDIC) | mdic.org ↗ |
| Biotechnology Innovation Organization (BIO) | bio.org ↗ |
| Int'l Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | ifpma.org ↗ |
| U.S. Pharmacopeia (USP) | usp.org ↗ |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | edqm.eu ↗ |
| World Organisation for Animal Health (WOAH) | woah.org ↗ |
| American Hospital Association (AHA) | aha.org ↗ |
| OECD Health | oecd.org/health ↗ |
| World Bank Data | data.worldbank.org ↗ |
Dermatology Drugs Market Size & Growth Forecast 2027–2036, By Segments (Route of Administration, Indication Type, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Dermatology Drugs Market size is estimated to increase from USD 35.7 billion in 2025 to USD 96.89 billion by 2035, supported by a CAGR exceeding 10.5% during 2026-2035. In 2026, re...
Oncology Molecular Diagnostic Market Size & Share, By Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Other Cancer), Technology (PCR, In Situ Hybridization, INAAT, Chips and Microarrays, Mass Spectrometry, Sequencing, TMA, Others), Product (Instruments, Reagents, Others ) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
The global oncology molecular diagnostic market size is set to grow from USD 2.25 billion in 2024 to USD 6.33 billion by 2034, reflecting a CAGR of more than 10.9% between 2025 and...
Hepatitis B Market Size & Share, By Type (Acute, Chronic), Treatment (Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery (Liver Transplant)), Distribution Channel (Hospital & Retail Pharmacies, Online Pharmacies) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
The global hepatitis b market size is forecast to grow from USD 4.75 billion to USD 6.57 billion between 2025 and 2034, marking a CAGR of more than 3.3%.
Clinical Trial Supply and Logistics Market Size & Share, By Service (Logistics & Distribution, Storage & Retention, Packaging, Labeling, and Blinding, Manufacturing, Comparator Sourcing, Others), Phase (Phase I, Phase II, Phase III, Phase IV), End-user (Pharmaceuticals, Biologicals, Medical Device), Therapeutic Area (Oncology, Cardiovascular Diseases, Respiratory Diseases, CNS and Mental Disorders, Others) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
The global clinical trial supply and logistics market size is expected to expand from USD 3.98 billion in 2024 to USD 8.36 billion by 2034, demonstrating a CAGR of more than 7.7% b...
Ultra Low Temperature Freezer Market Size & Share, By Product Type (Upright ULT freezers, Chest ULT freezers), End-user (Bio-Banks, Pharmaceutical and Biotechnology Companies, Academic and Research Laboratories, Others ) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
The global ultra low temperature freezer market size is anticipated to grow significantly, reaching USD 1.72 billion by 2034, up from USD 917.33 million. This growth represents a C...
Pharmaceutical Contract Sales Outsourcing (CSO) Market Size & Share, By Service (Personal Promotion, Non-personal Promotion, Others), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, Others) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
The global pharmaceutical contract sales outsourcing (cso) market size is projected to rise from USD 10.82 billion in 2024 to USD 24.69 billion by 2034, representing a CAGR above 8...
Airway Clearance Devices Market Size & Growth Forecast 2027–2036, By Segments (Age Group, End Use, Application, Device Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Airway Clearance Devices Market size is forecasted to reach USD 1.09 billion by 2035, rising from USD 668.79 million in 2025, at a CAGR of more than 5% between 2026 and 2035. In 20...
PEGylation Proteins Market Size & Share, By Product & Services (Consumables, Services), Type (Colony-stimulating Factor, Interferons, Erythropoietin, Recombinant Factor VII, Others), Application (Cancer, Autoimmune Diseases, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorders, Others), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
The global pegylation proteins market size is predicted to grow from USD 2.13 billion in 2024 to USD 6.1 billion by 2034, reflecting a CAGR of over 11.1% from 2025 through 2034.
Cancer/Oncology Drugs Market Size & Share, By Drug Class (Targeted Therapy, Chemotherapy, Hormonal Therapy, and Immunotherapy), Indication (Lungs Cancer, Colorectal Cancer, Melanoma, Breast Cancer, Liver Cancer, Bladder Cancer, Head & Neck Cancer, Prostate Cancer, and Others) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
The global cancer/oncology drugs market size is anticipated to grow significantly, reaching USD 499.35 billion by 2034, up from USD 171.18 billion. This growth represents a CAGR of...
Asthma Treatment Market Size & Share, By Medication (Quick-relief medication, Long-term control medication), Route of Administration (Inhalers, Prefilled syringes/vials, Others), Adjunct Therapy (LAMA, LABA, Others), Distribution Channel (Online pharmacies, Hospital pharmacies, Retail pharmacies & drug stores) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
The global asthma treatment market size is anticipated to grow significantly, reaching USD 35.6 billion by 2034, up from USD 28.08 billion. This growth represents a CAGR of over 2....
Need an Industry Research study we haven't published yet?
Our Healthcare team scopes custom studies using the same interview network and validation framework — typically delivered in 2–3 weeks.